TP53 and cancer: In sum, mut-p53 can impinge on several aspects of the communication between cancer cells and immune-inflammatory cell populations of the TME, thereby evoking tumor-supporting inflammation, while concomitantly suppressing innate immune signaling and favoring immune evasion.